Clinical Study
Safety and Effectiveness of Bone Marrow Cell Concentrate in the Treatment of Chronic Critical Limb Ischemia Utilizing a Rapid Point-of-Care System
Figure 2
(a) Analysis of changes in ABI from baseline to 12 months (; ; ). (b) Analysis of changes in TcPO2 from baseline to 12 months (; ; ).
(a) |
(b) |